Realizing an innovative therapeutic platform for the functional and aesthetic restoration of various types of complex tissue defects and injury by deploying next-generation advanced adipose-derived stem cell (ADSC) technologies within harsh clinical microenvironments.
Precisely replicating clinical unmet needs such as acquired radiation and chemo-resistance within in vivo animal models, and establishing high-throughput screening and validation platforms to rapidly discover novel therapeutic candidates that overcome these intractable barriers.
Investigating materials to control and eradicate bacterial biofilms, which serve as major healing barriers in chronic wounds and infectious defects.
Establishing a seamless bridge between real-world clinical practice and laboratory research by linking patient-derived biospecimens with precision preclinical models, thereby rigorously validating the therapeutic efficacy, safety, and clinical feasibility of advanced therapeutics.
